Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Bio-Techne Corp/ 10-Q

Quarterly Report · 10-Q

Bio-Techne Corp

TECHNASDAQEQUITYCurrent

Quarterly Report

Filed Feb 4, 2026Accepted Feb 4, 2026, 4:31 PM ESTCIK 842023Accession 0001104659-26-010335
View company →Permanent SEC source ↗
Share

Company context

Bio Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota, celebrating 50 years of empowering scientific and diagnostic communities to reach better answers. The company provides high quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer focused brands: R&D Systems™, Bio Techne Spatial™, and Bio Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical decision making. Bio Techne operates in 34 locations worldwide and employs more than 3,000 people. In fiscal year 2025, the company generated over $1.2 billion in net sales. Its more than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.

Current securities

TECHNASDAQ · EQUITY · Current

Recent company filings

  1. 10-Q filingNov 6, 2026
  2. SCHEDULE 13G/A - filed by FMR LLC regarding BIO-TECHNE CorpNov 5, 2026
  3. Other EventsNov 4, 2026
  4. 10-K/A filingOct 28, 2026
  5. Submission of Matters to a Vote of Security Holders · Regulation FD DisclosureSep 23, 2026

Registered securities in this filing

BIO-TECHNE Corp · 10-Q · Filed 2026-02-04

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $0.01 par value

Symbol
TECH
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: Duration_7_1_2025_To_12_31_2025_ETRsvdnh0ka0aobkiqkxqQ

Dimensions: Not supplied

Accession 000110465926010335 · 1 registered-security cover member

Read the exact SEC filing ↗

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.